Showing results (221-230 of 334) with videos related to
Sort By:
Pageof 34
Human Vaccines & Immunotherapeutics|October 3, 2013
Clinical validation of IFNγ/IL-10 and IFNγ/IL-2 FluoroSpot assays for the detection of Tr1 T cells and influenza vaccine monitoring in humansAnne Chauvat, Nadine Benhamouda, Alain Gey, et al.AIDS (London, England)|July 14, 2010
Immunogenicity and safety of an HIV-1 lipopeptide vaccine in healthy adults: a phase 2 placebo-controlled ANRS trialDominique Salmon-Céron, Christine Durier, Corinne Desaint, et al.The Lancet. Infectious Diseases|August 11, 2015
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trialDavid Rey, Lionel Piroth, Marie-Josée Wendling, et al.The Journal of Infectious Diseases|August 17, 2019
Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized TrialTino F Schwarz, Roderick A McPhee, Odile Launay, et al.The Journal of Rheumatology|February 19, 2013
Influence of environmental factors on disease activity in spondyloarthritis: a prospective cohort studyNadine Zeboulon-Ktorza, Pierre Yves Boelle, Roula Said Nahal, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 11, 2008
Immunological efficacy of a three-dose schedule of hepatitis A vaccine in HIV-infected adults: HEPAVAC studyOdile Launay, Sophie Grabar, Emmanuel Gordien, et al.Vaccines|July 2, 2021
Immunization Catch-Up for Newly Arrived Migrants in France: A Cross-Sectional Study among French General PractitionersSohela Moussaoui, Anne Marie Aurousseau, Sylvain Nappez, et al.Antiviral Therapy|November 18, 2009
A population analysis of weight-related differences in lopinavir pharmacokinetics and possible consequences for protease inhibitor-naive and -experienced patientsMarion Bouillon-Pichault, Vincent Jullien, Christophe Piketty, et al.Influenza and Other Respiratory Viruses|November 17, 2025
Relative Effectiveness of High-Dose vs. Standard-Dose Influenza Vaccines in Preventing Hospitalizations: A National Retrospective Cohort Study in France, 2022/2023 SeasonHélène Bricout, Marie-Cécile Levant, Pascal Crépey, et al.Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 26, 2024
The relative effectiveness of a high-dose quadrivalent influenza vaccine versus standard-dose quadrivalent influenza vaccines in older adults in France: a retrospective cohort study during the 2021-2022 influenza seasonHélène Bricout, Marie-Cécile Levant, Nada Assi, et al.Pageof 34